GB0224799D0 - Improved complex compositions - Google Patents

Improved complex compositions

Info

Publication number
GB0224799D0
GB0224799D0 GBGB0224799.7A GB0224799A GB0224799D0 GB 0224799 D0 GB0224799 D0 GB 0224799D0 GB 0224799 A GB0224799 A GB 0224799A GB 0224799 D0 GB0224799 D0 GB 0224799D0
Authority
GB
United Kingdom
Prior art keywords
technetium
aza
diaminedioxime
improved
complex compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0224799.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
Amersham PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham PLC filed Critical Amersham PLC
Priority to GBGB0224799.7A priority Critical patent/GB0224799D0/en
Publication of GB0224799D0 publication Critical patent/GB0224799D0/en
Priority to CNA2003801020619A priority patent/CN1708322A/zh
Priority to PCT/GB2003/004573 priority patent/WO2004037297A1/en
Priority to DE60322562T priority patent/DE60322562D1/de
Priority to BR0315578-1A priority patent/BR0315578A/pt
Priority to ES03772392T priority patent/ES2309361T3/es
Priority to CA002501684A priority patent/CA2501684A1/en
Priority to AU2003279444A priority patent/AU2003279444A1/en
Priority to AT03772392T priority patent/ATE402720T1/de
Priority to MXPA05004418A priority patent/MXPA05004418A/es
Priority to KR1020057006999A priority patent/KR20050070080A/ko
Priority to EP03772392A priority patent/EP1553986B1/en
Priority to JP2004546174A priority patent/JP2006508084A/ja
Priority to RU2005110960/15A priority patent/RU2005110960A/ru
Priority to NO20051811A priority patent/NO20051811L/no
Priority to ZA200502835A priority patent/ZA200502835B/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB0224799.7A 2002-10-25 2002-10-25 Improved complex compositions Ceased GB0224799D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB0224799.7A GB0224799D0 (en) 2002-10-25 2002-10-25 Improved complex compositions
RU2005110960/15A RU2005110960A (ru) 2002-10-25 2003-10-24 Конъюгаты комплексов тс и группировок, обеспечивающих направленную доставку, и их применение в диагностике методом магнито-резонансной визуализации
CA002501684A CA2501684A1 (en) 2002-10-25 2003-10-24 Conjugates of tc complexes and targeting moieties and their use in mri diagnostic
AT03772392T ATE402720T1 (de) 2002-10-25 2003-10-24 Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik
DE60322562T DE60322562D1 (de) 2002-10-25 2003-10-24 Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik
BR0315578-1A BR0315578A (pt) 2002-10-25 2003-10-24 Composição de complexo de tecnécio, produto radiofarmacêutico, kit para a preparação do produto radiofarmacêutico de tecnécio, e, método de formação de imagem de diagnóstico de trombos
ES03772392T ES2309361T3 (es) 2002-10-25 2003-10-24 Conjugados de complejos de tc y restos de direccionamiento y su uso en diagnostico por rmn.
CNA2003801020619A CN1708322A (zh) 2002-10-25 2003-10-24 锝络合物和靶标部分的共轭体及其在mri诊断中的用途
AU2003279444A AU2003279444A1 (en) 2002-10-25 2003-10-24 Conjugates of tc complexes and targeting moieties and their use in mri diagnostic
PCT/GB2003/004573 WO2004037297A1 (en) 2002-10-25 2003-10-24 Conjugates of tc complexes and targeting moieties and their use in mri diagnostic
MXPA05004418A MXPA05004418A (es) 2002-10-25 2003-10-24 Conjugados de complejos de tc y porciones enfocadoras y su uso en diagnostico de mri.
KR1020057006999A KR20050070080A (ko) 2002-10-25 2003-10-24 Ｔｃ 복합체와 표적화 잔기의 접합체 및 ＭＲＩ 진단에서의그의 용도
EP03772392A EP1553986B1 (en) 2002-10-25 2003-10-24 Conjugates of tc complexes and targeting moieties and their use in mri diagnostic
JP2004546174A JP2006508084A (ja) 2002-10-25 2003-10-24 Ｔｃ錯体と標的部分との複合体並びにＭＲＩ診断での使用
NO20051811A NO20051811L (no) 2002-10-25 2005-04-14 Conjugates of TC complexes and targeting moiettes and their use in mri diagnostic
ZA200502835A ZA200502835B (en) 2002-10-25 2006-01-19 Conjugates of TC complexes and targeting moieties and their use in MRI diagnostic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0224799.7A GB0224799D0 (en) 2002-10-25 2002-10-25 Improved complex compositions

Publications (1)

Publication Number Publication Date
GB0224799D0 true GB0224799D0 (en) 2002-12-04

Family

ID=9946533

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0224799.7A Ceased GB0224799D0 (en) 2002-10-25 2002-10-25 Improved complex compositions

Country Status (16)

Country Link
EP (1) EP1553986B1 (enExample)
JP (1) JP2006508084A (enExample)
KR (1) KR20050070080A (enExample)
CN (1) CN1708322A (enExample)
AT (1) ATE402720T1 (enExample)
AU (1) AU2003279444A1 (enExample)
BR (1) BR0315578A (enExample)
CA (1) CA2501684A1 (enExample)
DE (1) DE60322562D1 (enExample)
ES (1) ES2309361T3 (enExample)
GB (1) GB0224799D0 (enExample)
MX (1) MXPA05004418A (enExample)
NO (1) NO20051811L (enExample)
RU (1) RU2005110960A (enExample)
WO (1) WO2004037297A1 (enExample)
ZA (1) ZA200502835B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0515974D0 (en) * 2005-08-03 2005-09-07 Ge Healthcare Ltd Compounds and imaging methods
GB0520527D0 (en) * 2005-10-10 2005-11-16 Ge Healthcare Ltd Automated method
GB0614337D0 (en) * 2006-07-19 2006-08-30 Acal Energy Ltd Fuel Cells
US20120165650A1 (en) 2010-12-22 2012-06-28 General Electric Company Her2 binders
ES2804509T3 (es) 2010-07-27 2021-02-08 Serac Healthcare Ltd Composiciones radiofarmacéuticas
ES2739504T3 (es) 2010-12-21 2020-01-31 Ge Healthcare Ltd Uso de anilina en la radioestabilización de una ligadura de oxima
JP5934246B2 (ja) * 2010-12-22 2016-06-15 テーエフシム グリコ−ｃｆ２−セリンおよびグリコ−ｃｆ２−トレオニンの誘導体
GB201103696D0 (en) * 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
US20130195756A1 (en) * 2012-01-31 2013-08-01 General Electric Company 99mTc IMAGING AGENTS AND METHODS OF USE
GB201610176D0 (en) * 2016-06-10 2016-07-27 Edinburgh Molecular Imaging Ltd Imaging agents and methods of use
CN112830940B (zh) * 2020-09-07 2022-03-01 中国科学院宁波材料技术与工程研究所 2,5-呋喃二甲醛肟金属络合物及其制备方法、及在抗菌除霉消毒剂中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69937996T2 (de) * 1998-05-15 2009-01-02 Ge Healthcare Ltd., Little Chalfont Markierte glutamin- und lysinanaloge
WO2001077145A2 (en) * 2000-04-12 2001-10-18 Amersham Health As Integrin binding peptide derivatives
WO2001089584A2 (en) * 2000-05-23 2001-11-29 Amersham Health As Contrast agents
NO20004795D0 (no) * 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
GB0105224D0 (en) * 2001-03-02 2001-04-18 Nycomed Amersham Plc Improved peptide-chelate conjugates

Also Published As

Publication number Publication date
BR0315578A (pt) 2005-10-25
KR20050070080A (ko) 2005-07-05
WO2004037297A1 (en) 2004-05-06
NO20051811D0 (no) 2005-04-14
ES2309361T3 (es) 2008-12-16
CN1708322A (zh) 2005-12-14
MXPA05004418A (es) 2005-11-23
EP1553986A1 (en) 2005-07-20
DE60322562D1 (de) 2008-09-11
RU2005110960A (ru) 2005-11-20
ZA200502835B (en) 2006-03-29
ATE402720T1 (de) 2008-08-15
EP1553986B1 (en) 2008-07-30
CA2501684A1 (en) 2004-05-06
JP2006508084A (ja) 2006-03-09
AU2003279444A1 (en) 2004-05-13
NO20051811L (no) 2005-06-27

Similar Documents

Publication Publication Date Title
BR0210965A (pt) Conjugado de quelador, complexo de radiometal, radiofármaco, kit para a preparação do mesmo, composto, e, processo para a preparação do mesmo
MXPA05008356A (es) Composiciones complejas mejoradas de radiometal.
Liu Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides
CA2958475C (en) Mono-, di- or oligosaccharide used as metal inhibitors in the preparation of radioactive metal-chelate-functionalized target agents
GB0224799D0 (en) Improved complex compositions
AU3602795A (en) Tc or re radiolabelled somatostatin analogs
UA32577C2 (uk) Радіомічена сполука для утворення зображення тромбів при радіонуклідній діагностиці, радіофармацевтичний препарат та радіофармацевтична композиція на їх основі та комплект для приготування радіофармацевтичних препаратів
EP0329481A3 (en) Anchimeric radiometal chelating compounds
Liu et al. Labeling biomolecules with radiorhenium-A review of the bifunctional chelators
Franz et al. The production of 99mTc-labeled conjugated antibodies using a cyclam-based bifunctional chelating agent
WO2005053752A3 (en) Novel imaging agents comprising caspase-3 inhibitors
WO2007042781A3 (en) Automated method for preparing technetium complexes
GB0105224D0 (en) Improved peptide-chelate conjugates
SI1603598T1 (sl) Radiooznačeni konjugati na osnovi substance P innjihove uporabe
Biechlin et al. Improvement in radiolabelling proteins with the 99mTc‐tricarbonyl‐core [99mTc (CO) 3]+, by thiol‐derivatization with iminothiolane: application to γ‐globulins and annexin V
Banerjee et al. Site directed maleimide bifunctional chelators for the M (CO) 3+ core (M= 99m Tc, Re)
WO2006037988A3 (en) Novel technetium and rhenium complexes, ligands used in their preparation and their use as radiopharmaceuticals
WO2003027148A8 (en) Disulfide-reduced neogalactosyl serum albumin and use of radiolabeled derivative thereof for liver imaging
NO20055334L (no) Bifunksjonelle tridentate pyrazolylinneholdende ligander for RE og TC trikarbonylkomplekser
Riss et al. NODAPA-OH and NODAPA-NCS: Mono-and multimeric six-coordinate Ga-chelators

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)